Pharmaceutical Executive-01-27-2009

Trending on PharmExec

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma

Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds